Episode Details

Health campaigners challenge UK government over US drug-pricing deal, threatening legal action for allegedly breaking parliamentary rules and giving ministers more power over NHS medicine spending. The deal, struck in December, promises increased NHS spending on new medicines in exchange for tariff-free access to the American pharmaceutical market. Campaigners argue that such a significant shift in how NICE operates should have gone through a full parliamentary debate, not just secondary legislation with limited scrutiny. The government is expected to respond within days, with a potential judicial review looming if demands for transparency and debate are not met.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/083c098b68550dd9